Current Rheumatology Reviews
Scope & Guideline
Delivering critical reviews for informed clinical practice.
Introduction
Aims and Scopes
- Clinical Management of Rheumatic Diseases:
The journal emphasizes research on the diagnosis, management, and treatment of various rheumatic diseases, including rheumatoid arthritis, systemic lupus erythematosus, osteoarthritis, and more. It aims to address both traditional and novel therapeutic approaches. - Genetic and Molecular Insights:
Research articles frequently explore genetic polymorphisms, biomarkers, and molecular mechanisms underlying rheumatic diseases, contributing to a better understanding of disease pathogenesis and potential targets for therapy. - Patient Quality of Life and Health Outcomes:
A significant focus is placed on studies assessing the impact of rheumatic diseases on patients' quality of life, functional ability, and psychological well-being, highlighting the importance of holistic patient care. - Emerging Therapies and Innovative Treatments:
The journal covers novel therapeutic strategies, including biologics, small molecules, and complementary approaches, providing insights into the latest advancements in treatment options for rheumatic conditions. - Epidemiological Studies and Public Health:
Current Rheumatology Reviews includes epidemiological research that examines the prevalence, risk factors, and health disparities related to rheumatic diseases, contributing to public health knowledge and policy.
Trending and Emerging
- Precision Medicine and Personalized Therapy:
There is a growing emphasis on precision medicine approaches, exploring how genetic, environmental, and lifestyle factors can be integrated into personalized treatment plans for patients with rheumatic diseases. - Impact of COVID-19 on Rheumatic Diseases:
The journal has seen a surge in research exploring the effects of COVID-19 on patients with rheumatic conditions, including disease activity and treatment responses, reflecting the pandemic's profound impact on healthcare. - Role of the Microbiome in Rheumatic Diseases:
Emerging studies are increasingly investigating the connections between the microbiome and autoimmune diseases, suggesting a novel area of research that may lead to innovative therapeutic strategies. - Use of Digital Health Technologies:
The integration of digital health technologies, such as telemedicine and mobile health applications, is becoming a prominent theme, focusing on improving patient management and access to care. - Interdisciplinary Approaches to Rheumatology:
There is a trend towards interdisciplinary research that combines rheumatology with other fields such as neurology, cardiology, and endocrinology, addressing the complex interplay of comorbidities in rheumatic diseases.
Declining or Waning
- Traditional Therapies and Older Treatments:
There has been a noticeable decrease in studies focusing on older treatment modalities, such as non-steroidal anti-inflammatory drugs (NSAIDs) and corticosteroids, as newer therapies gain prominence. - Aging-Related Rheumatic Conditions:
Research specifically addressing aging-related rheumatic conditions has waned, suggesting a shift towards more contemporary issues in rheumatology such as autoimmunity and genetic predispositions. - Basic Science Research:
There is a declining trend in purely basic science studies that do not directly connect to clinical applications, as the journal increasingly emphasizes translational research that links laboratory findings to patient care. - Generalized Epidemiological Surveys:
While epidemiological research remains important, there appears to be a decline in generalized surveys that do not focus on specific populations or diseases, favoring more targeted studies.
Similar Journals
Reumatismo
Connecting researchers and practitioners in the world of rheumatology.Reumatismo is a distinguished Open Access journal dedicated to the field of rheumatology, published by PAGEPRESS PUBL since 2001. With a rich history dating back to 1952, this journal has been pivotal in disseminating vital research on rheumatic diseases and related disorders. Based in Italy, Reumatismo has earned a reputation for its quality and relevance, achieving a Q3 category ranking in the 2023 Scopus metrics for Rheumatology, reflecting its significant contributions to the field. The journal is committed to providing a platform for the latest scientific developments and clinical innovations, thus aiding researchers, healthcare professionals, and students striving to enhance understanding and treatment of rheumatic conditions. For those seeking to access comprehensive research articles and studies, Reumatismo boasts an open access policy, ensuring that knowledge is freely available to all, fostering collaboration and advancement in rheumatology worldwide.
Modern Rheumatology
Advancing the Future of RheumatologyModern Rheumatology is a premier journal dedicated to advancing the field of rheumatology through high-quality peer-reviewed research. Published by Oxford University Press, this journal reflects the latest developments in rheumatologic medicine, catering to researchers, clinicians, and students alike. With an H-Index highlighting its scholarly impact, Modern Rheumatology occupies a notable position, ranking Q2 in both the fields of Medicine and Rheumatology in 2023, and is listed among the top 25 journals in its category by Scopus. Spanning from the year 2000 to 2024, the journal features a diverse array of topics aimed at addressing current challenges and innovations in the field. Although it does not offer Open Access, it provides essential insights for professionals seeking to stay abreast of evolving treatment modalities and research breakthroughs. Located in the heart of the United Kingdom, Modern Rheumatology is a vital resource for anyone committed to enhancing the understanding and treatment of rheumatic diseases.
ZEITSCHRIFT FUR RHEUMATOLOGIE
Enhancing patient care with groundbreaking rheumatology insights.ZEITSCHRIFT FUR RHEUMATOLOGIE, published by Springer Heidelberg, serves as a vital platform in the field of rheumatology, providing researchers, clinicians, and students with cutting-edge findings and discussions related to the diagnosis, treatment, and management of rheumatic diseases. Since its inception in 1974 and continuing until 2024, this journal retains its commitment to disseminating significant scientific work within this specialized domain. Although it is currently categorized in the Q4 quartile for Rheumatology and ranks 47 out of 73 in Scopus, reflecting its burgeoning presence, the journal is dedicated to evolving and gaining prominence in the academic community. By offering valuable insights and fostering scholarly discourse, ZEITSCHRIFT FUR RHEUMATOLOGIE plays a crucial role in advancing rheumatology research and enhancing patient care practices worldwide. The journal presents an opportunity for its readers to engage with contemporary studies and enrich their understanding of rheumatic ailments.
Egyptian Rheumatologist
Championing excellence in rheumatology studies.The Egyptian Rheumatologist is a peer-reviewed Open Access journal dedicated to advancing the field of rheumatology. Published by Elsevier since 2011, the journal aims to disseminate high-quality research, clinical innovations, and reviews that cover a wide range of topics related to autoimmune diseases, arthritis, and musculoskeletal disorders. With an ISSN of 1110-1164 and an E-ISSN of 2090-2433, it has achieved a respectable rank of #50 out of 73 in the medicine/rheumatology category according to Scopus, positioning it in the 32nd percentile among its peers. Operating from its base in Amsterdam, Netherlands, the journal provides an accessible platform for researchers, professionals, and students, encouraging a collaborative exchange of cutting-edge knowledge that is essential for the ongoing developments in rheumatologic care and research. The Open Access model ensures that critical findings and advancements are available to a global audience, fostering further research and education within this vital field.
Pediatric Rheumatology
Advancing pediatric care through groundbreaking research.Pediatric Rheumatology is a leading peer-reviewed open access journal published by BMC, dedicated to disseminating high-quality research in the field of pediatric rheumatology. Since its inception in 2007, the journal has established itself as a vital resource for healthcare professionals, researchers, and students focused on pediatric immunology, rheumatology, and child health, maintaining an impressive Q1 ranking in Pediatrics and Q2 in Immunology and Allergy as well as Rheumatology for 2023. It is recognized for its impact on advancing knowledge and clinical practice, with significant contributions noted in various studies and case reports. With access options that embrace the ethos of open science, all articles published in Pediatric Rheumatology are freely available, promoting collaborative research and discussion among practitioners across the globe. The journal welcomes submissions that encapsulate innovative research, clinical trials, and reviews that address both current challenges and advancements within the pediatric rheumatology landscape.
Archives of Rheumatology
Empowering researchers to reshape rheumatic disease management.Archives of Rheumatology is a premier peer-reviewed journal dedicated to advancing the field of rheumatology through the dissemination of high-quality research, reviews, and case studies. Published by the Turkish League Against Rheumatism, this open-access journal provides a platform for researchers, clinicians, and students to share insightful findings and innovative approaches in the diagnosis and management of rheumatologic diseases. With the goal of promoting knowledge exchange on a global scale, the journal welcomes submissions that enhance understanding and foster advancements in the clinical and biological aspects of rheumatic conditions. Each publication contributes significantly to the growing body of literature in this vital field of medicine, making Archives of Rheumatology an essential resource for both established and emerging researchers looking to stay abreast of the latest developments and clinical practices.
European Journal of Rheumatology
Elevating Standards in Rheumatology ScholarshipEuropean Journal of Rheumatology is a premier, peer-reviewed journal that has been paving the way for innovative research and in-depth analysis in the field of rheumatology since its launch. Published by AVES, this Open Access journal has been accessible to researchers, professionals, and students worldwide since 2014, promoting the sharing of valuable knowledge on rheumatic diseases and their treatment. With an ISSN of 2147-9720 and an E-ISSN of 2148-4279, it provides a prominent platform for groundbreaking studies and clinical evaluations that bridge scientific discovery with practical application. The journal’s mission is to enhance the understanding of rheumatological conditions and facilitate advancements in therapeutic strategies, making it an essential resource for anyone devoted to the improvement of patient care in this dynamic field. The European Journal of Rheumatology is committed to upholding the highest standards of scholarly publishing and aims to foster collaboration among researchers and practitioners across Europe and beyond.
Arthritis & Rheumatology
Connecting Researchers to Transformative DiscoveriesArthritis & Rheumatology is a leading journal dedicated to the advancement of knowledge in the fields of rheumatology, immunology, and allergy. Published by WILEY in the United Kingdom, this prestigious journal boasts an impressive impact factor and a prominent reputation, ranking in the Q1 category across multiple disciplines, including Immunology and Rheumatology. With its high ranking of 4th out of 73 in Rheumatology and notable standings in related fields, it serves as a crucial platform for researchers, healthcare professionals, and scholars to disseminate groundbreaking findings. The journal embraces an Open Access model, enhancing the accessibility of vital research to a global audience and ensuring that knowledge dissemination is maximized. Since its inception in 2014, Arthritis & Rheumatology has been at the forefront of impactful research, fostering collaboration and innovation in tackling complex challenges within these medical disciplines. Researchers looking to explore the latest advancements and engage with cutting-edge studies in these fields will find this journal to be an essential resource.
BMC Rheumatology
Innovating insights for a healthier future in rheumatology.BMC Rheumatology is a vital open-access journal that has been disseminating high-quality research in the field of rheumatology since its inception in 2017. Published by Springer Nature, this journal provides a platform for original research, reviews, and clinical studies that advance the understanding and treatment of rheumatic diseases. With a commendable impact factor and ranked in the second quartile (Q2) for Rheumatology as of 2023, BMC Rheumatology exemplifies expertise, contributing significantly to the medical community's dialogue. Researchers, professionals, and students will find valuable insights within its pages, as it caters to a diverse audience through its commitment to open-access publishing, facilitating knowledge sharing without barriers. Based in the United Kingdom and indexed in Scopus, the journal continues to thrive with a steady convergence of academic excellence through 2024, making it an indispensable resource for those dedicated to advancing rheumatological science.
Revista Cubana de Reumatologia
Fostering innovation in the management of rheumatic conditions.Revista Cubana de Reumatologia is a prominent open-access journal published by the SOC CUBANA REUMATOLOGIA, dedicated to advancing knowledge in the field of rheumatology since its inception in 1998. With an ISSN of 1606-5581 and an E-ISSN of 1817-5996, this journal aims to disseminate high-quality research that addresses various aspects of rheumatic diseases, their diagnosis, treatment, and management. Located in Havana, Cuba, the journal serves as a vital platform for both local and international researchers, professionals, and students interested in the latest developments within the specialty. By embracing an open-access policy, the journal ensures that groundbreaking studies are freely available to a global audience, fostering collaboration and innovation in rheumatological research. As the field continues to evolve, Revista Cubana de Reumatologia remains committed to addressing the emerging challenges and trends, making it an essential resource for practitioners and scholars alike.